Trial intelligence / Profile preview

Gamma-OH for Sleep in ICU Weaning

NCT04224246Phase 2Completed

Sponsor
CHU de Poitiers
Start
Feb 2020
Primary completion
Feb 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of sodium oxybate in sleep deprivation, sponsored by CHU de Poitiers. Started Feb 2020; status: completed.

02

Drugs

sodium oxybate
03

Conditions

sleep deprivation

Beyond the preview

Go deeper on NCT04224246.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04224246.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call